For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Fukuoka 831-0016
0 studies enrolling now · 34 studies all time
What they study most
Alzheimer's Disease, Atopic Dermatitis, Autoimmune Disease, Cardiovascular Diseases, Colorectal Cancer, Connective Tissue Disease, Diabetes Mellitus, Type 1, Diabetic Kidney Disease, Femur Neck Fracture, Gastroesophageal Junction Adenocarcinoma, Hepatocellular Carcinoma, Hypercholesterolemia
Studies at this site
- A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer — Completed
- A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein — Completed
- A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer — Completed
- A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
- A Study of LY3337641 in Rheumatoid Arthritis — Stopped early
- A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
- Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease — Stopped early
- A Phase 3 Study in Participants With Moderate to Severe Psoriasis — Completed
- A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease — Completed
- A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis — Completed
- A Study in Second Line Metastatic Colorectal Cancer — Completed
- A Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
- A Study in Moderate to Severe Rheumatoid Arthritis — Completed
- A Moderate to Severe Rheumatoid Arthritis Study — Completed
- A Study of LY3015014 in Participants With High Cholesterol — Completed
- A Study of Ixekizumab in Participants With Active Psoriatic Arthritis — Completed
- A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) — Completed
- PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin — Completed
- A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
- An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
- A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement — Completed
- A Study in Participants With Rheumatoid Arthritis — Stopped early
- A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate — Stopped early
- A Rheumatoid Arthritis Study in Participants — Completed
- A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment — Completed
- A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder — Completed
- Effect of Teriparatide on Hip Fracture Healing — Completed
- Effect of LY450139 on the Long Term Progression of Alzheimer's Disease — Completed
- Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
- A Study in Adults With Type 1 Diabetes — Completed
- A Study of Semagacestat for Alzheimer's Patients — Completed
- Effect of LY2062430 on the Progression of Alzheimer's Disease — Completed
- Effect of LY2062430 on the Progression of Alzheimer's Disease — Completed